Related Experiment Video
Updated: Jul 16, 2026

08:34
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
50.1K
Binocular Home Treatment for Amblyopia: Gains Stable for One Year
Tamara Wygnanski-Jaffe1, Avital Moshkovitz2, Burton J Kushner3
1Goldschleger Eye Institute, Sheba Medical Center (T.W.-J.), Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel-Aviv University (T.W.-J., M.B.), Tel-Aviv, Israel.
American Journal of Ophthalmology
|February 15, 2024
Summary
Binocular eye-tracking treatment for amblyopia (CureSight) maintained visual acuity and stereoacuity gains one year post-treatment. Some amblyopia recurrence was observed, highlighting the need for continued monitoring.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Vision Science
Background:
- Amblyopia, or 'lazy eye,' affects visual development in children.
- Effective amblyopia treatment is crucial for long-term visual function.
- Home-based, technology-driven treatments offer potential for improved accessibility.
Purpose of the Study:
- To evaluate the long-term outcomes of a binocular eye-tracking-based home treatment (CureSight) for amblyopia.
- To assess the durability of visual acuity and stereoacuity gains one year after treatment cessation.
- To determine the rate of amblyopia recurrence following treatment.
Main Methods:
- A prospective, multicenter, long-term follow-up observational study.
- 38 children with amblyopia were evaluated at 12 weeks and 27 at 1 year post-treatment.
- Main outcome measures included visual acuity (VA), stereoacuity, and amblyopia recurrence.
Main Results:
- Visual acuity gains were maintained at 12 weeks post-treatment and partially retained at 1 year.
- Stereoacuity and binocular visual acuity gains were sustained at both 12 weeks and 1 year.
- Amblyopia recurrence was observed in 5.3% of patients at 12 weeks and 20.4% at 1 year.
Conclusions:
- Binocular treatment with CureSight demonstrated sustained improvements in visual acuity and stereoacuity one year post-treatment.
- The observed gains were maintained without the need for additional amblyopia therapy.
- While generally effective, some recurrence necessitates ongoing patient follow-up.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

